Estrone is one of the three main forms of estrogen your body produces, and on a blood test it shows up as a marker of how much of this particular estrogen is circulating in your system. Unlike estradiol, which gets most of the attention in fertility and reproductive health, estrone is the dominant estrogen after menopause and plays a quieter but clinically meaningful role across a range of conditions. Your doctor may order an estrone test to investigate unexplained symptoms, monitor hormone therapy, or assess risk factors tied to estrogen-sensitive cancers. Understanding what the number on your lab report actually tells you requires some context about how estrone behaves differently from other estrogens and why it matters for your specific situation.
How Estrone Fits Into the Estrogen Family
Your body makes three major estrogens: estradiol, estrone, and estriol. Estradiol is the most potent and is the primary estrogen during reproductive years. Estriol rises dramatically during pregnancy. Estrone sits in the middle in terms of biological strength and takes center stage at a specific life stage: after menopause, when the ovaries largely stop producing estradiol, estrone becomes the most abundant circulating estrogen.
Estrone is produced mainly through the conversion of a precursor hormone called androstenedione. This conversion happens in fat tissue, the adrenal glands, and other peripheral tissues rather than primarily in the ovaries. That matters because it means estrone production does not shut down after menopause the way estradiol does. In fact, enough estrone can be produced through this process in peripheral tissues to be converted back into estradiol, and in some cases this secondary production is sufficient to cause clinical effects like uterine bleeding or endometrial changes in postmenopausal or obese women.1Journal of the American Academy of Dermatology. Estrogen production and action
There is also a stored form called estrone sulfate, which circulates at much higher concentrations than free estrone. Think of estrone sulfate as a reservoir: tissues that need estrogen can pull from this pool and convert estrone sulfate into active estrone or estradiol locally.2Journal of Steroid Biochemistry. Estrone sulfatase activity in the human brain and estrone sulfate levels in the normal menstrual cycle Some blood tests measure free estrone, others measure estrone sulfate, and the distinction matters for interpreting results, so it is worth checking which one your lab reported.
Why Your Doctor Ordered an Estrone Test
Estrone blood tests are not routine. If one shows up on your lab order, your doctor likely has a specific clinical question in mind. The most common reasons include evaluating menopausal status or unexplained postmenopausal bleeding, assessing estrogen levels in someone on hormone replacement therapy, investigating the hormonal environment around an estrogen-sensitive cancer, or monitoring aromatase inhibitor therapy designed to suppress estrogen production. In men, estrone testing sometimes comes up when investigating gynecomastia (breast tissue growth) or when liver disease is suspected of disrupting hormone metabolism.
An estrone test alone rarely tells the full story. It is almost always interpreted alongside other hormones, particularly estradiol, follicle-stimulating hormone (FSH), and luteinizing hormone (LH). During the transition into menopause, for example, estrone correlates positively with LH during early stages, while FSH tracks more closely with estradiol in later stages.3PubMed Central. Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition Your doctor uses the pattern across multiple hormones, not a single estrone value in isolation, to figure out what is going on.
What the Numbers Mean
Reference ranges for estrone vary depending on your age, sex, and menopausal status, and they also vary between labs. In premenopausal women, estrone fluctuates across the menstrual cycle. Research tracking daily levels through the cycle has found that estrone rises at midcycle and again during the luteal phase, mirroring estradiol’s pattern but with a less dramatic swing. One early measurement study found values roughly quadrupling from menstruation to the midcycle peak.4The Journal of Clinical Endocrinology & Metabolism. Concentration of Unconjugated Estrone and Estradiol in Peripheral Plasma in Nonpregnant Women Throughout the Menstrual Cycle, Castrate and Postmenopausal Women and in Men Estrone also shows a distinct daily rhythm, dipping to its lowest point in the middle of the night.5The Journal of Clinical Endocrinology & Metabolism. A Radio-ligand Assay for Plasma Estrone; Normal Values and Variations During the Menstrual Cycle This means the time of day and the point in your cycle when your blood was drawn can meaningfully shift the result.
After menopause, estradiol drops sharply but estrone falls less steeply because fat tissue keeps producing it. In postmenopausal women, estrone is typically the estrogen present in the highest concentration, and values vary widely depending on body composition and other individual factors.
During pregnancy, all three estrogens rise dramatically. Estrone, estradiol, and estriol all increase substantially as pregnancy progresses.6Molecular and Cellular Probes. Reference data on estrogen metabolome in healthy pregnancy If you are pregnant and see a high estrone value, that is expected physiology, not a red flag.
Because labs use different assay methods with different calibration standards, the reference range printed on your report is the one to use when interpreting your result. A value that looks high on one lab’s scale could be mid-range on another’s. Always compare your number to the specific range your lab provides.
Body Weight and Estrone Levels
One of the strongest and most consistent findings in estrone research is the connection between body weight and estrone production. Fat tissue contains the enzyme aromatase, which converts androstenedione into estrone. More fat tissue means more aromatase activity and higher circulating estrone. This relationship has been confirmed repeatedly in postmenopausal women, where body mass index shows a clear positive correlation with estrone, estradiol, and estrone sulfate levels.7Maturitas. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women
What makes this particularly interesting is that obesity and aging appear to amplify each other’s effects. Research comparing premenopausal and postmenopausal women of similar weight found that the conversion of androstenedione to estrone was considerably greater in the postmenopausal group.8American Journal of Obstetrics and Gynecology. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer Increasing body size in postmenopausal women is also associated with higher rates of hypertension, diabetes, and lower HDL cholesterol alongside the higher estrone.9Maturitas. Obesity, estrone, and coronary artery disease in postmenopausal women
If your estrone level comes back elevated and you carry significant excess weight, the connection is likely at least partly straightforward: your fat tissue is producing more estrone than average. That does not make the elevation harmless, as the downstream effects of chronically elevated estrone are real, but it does point to body composition as a modifiable factor.
Estrone and Cancer Risk
The link between circulating estrogens and breast cancer in postmenopausal women is well established, and estrone is part of that picture. Prospective studies have found that higher serum estrone levels are associated with increased breast cancer risk in postmenopausal women.10PubMed Central. Serum Sex Hormone Levels Are Related to Breast Cancer Risk in Postmenopausal Women A study of postmenopausal Japanese women found that women in the highest third of estrone levels had roughly four times the risk of breast cancer compared with women in the lowest third. That elevated risk was driven almost entirely by estrogen-receptor-positive tumors. Women with the highest estrone levels had dramatically higher odds of receptor-positive breast cancer but no significant increase in receptor-negative breast cancer.11PubMed. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women
The endometrium is also estrogen-sensitive, and the same aromatase-driven estrone production that rises with body weight can increase the risk of endometrial hyperplasia and endometrial cancer in postmenopausal and anovulatory women.1Journal of the American Academy of Dermatology. Estrogen production and action This is one reason why unexplained postmenopausal bleeding often triggers an estrone test: the doctor is looking for evidence that ongoing estrogen production is stimulating the uterine lining when it should be quiescent.
A high estrone level does not mean you have cancer or will develop it. These are population-level risk associations. But persistently elevated estrone is something oncologists and gynecologists take seriously when evaluating a patient’s overall hormonal risk profile, particularly for estrogen-receptor-positive cancers.
Estrone in Men
Men produce estrone too, primarily through the same aromatase conversion of androgens in fat tissue and the adrenal glands. Estrone levels in healthy men are low, and the test is not commonly ordered unless there is a clinical reason to check.
One of those reasons is gynecomastia. In a large family study of inherited aromatase overactivity, researchers found that excess serum estrone with normal estradiol levels was the only reliable blood marker pointing to the condition, which included prepubertal gynecomastia and moderate hypogonadism in affected men.12The Journal of Clinical Endocrinology & Metabolism. Dominant Transmission of Prepubertal Gynecomastia Due to Serum Estrone Excess: Hormonal, Biochemical, and Genetic Analysis in a Large Kindred In other words, estradiol can look perfectly normal while estrone is quietly elevated, and that elevation alone can drive visible feminizing effects.
Liver disease is another context. In men with cirrhosis, plasma estrone tends to be elevated while estrone sulfate drops, likely because the damaged liver is less efficient at sulfating (deactivating) estrone for storage.13PubMed. Steroid sulfatase activities in normal and cirrhotic livers and plasma levels of estrone sulfate, estrone and estradiol-17 beta in men If your doctor orders an estrone test in the context of liver disease, they are looking at whether hormonal imbalance is contributing to symptoms like gynecomastia or other signs of estrogen excess.
How the Test Is Run and Why the Method Matters
This is an area where the science genuinely affects what your results mean, and most patients never hear about it. There are two main categories of lab methods used to measure estrone: immunoassay-based methods (like chemiluminescence immunoassay, or CLIA) and mass spectrometry-based methods (LC-MS/MS). Most commercial labs use immunoassays because they are cheaper and faster. Specialty and reference labs increasingly use mass spectrometry.
The problem is that these methods do not always agree. When researchers compared LC-MS/MS measurements of estrone with two major commercial immunoassay platforms, the correlation was good overall but the discrepancies in individual samples could be striking. In one case, the mass spectrometry method reported a value around 12 pg/mL while the two immunoassay kits returned 34 and 48 pg/mL for the same blood sample.14Medical Mass Spectrometry. Development and validation of the simultaneous measurement of estrone and 17 beta estradiol in serum by LC MS/MS for clinical laboratory applications That is a three- to four-fold difference depending on the platform, which could easily push a normal result into the abnormal range or vice versa.
Mass spectrometry is generally considered the more accurate technique, especially at low concentrations, which is exactly the range that matters for postmenopausal women and patients on aromatase inhibitors.15Clinica Chimica Acta. Liquid chromatography tandem mass spectrometry assay for fast and sensitive quantification of estrone-sulfate Immunoassays tend to show a positive bias, meaning they read higher than mass spectrometry for the same sample, and researchers have flagged this as a reason to reconsider clinical conclusions that relied on immunoassay-derived sex hormone data.16Journal of Pharmaceutical and Biomedical Analysis. An LC-MS/MS analysis for seven sex hormones in serum
The practical takeaway: if you are tracking estrone over time, getting your blood drawn at the same lab using the same method each time matters. Switching labs or methods between tests can introduce apparent changes that are really just measurement noise. If your doctor is making a clinical decision based on estrone levels and the value is borderline, it is reasonable to ask whether the lab used immunoassay or mass spectrometry.
Oral Versus Transdermal Hormone Therapy
If you are on estrogen-based hormone replacement therapy and your estrone level looks unexpectedly high, the route of administration may explain it. Oral estrogen pills pass through the liver before reaching the rest of the body. During that first pass, the liver converts a significant portion of the estradiol into estrone, which drives estrone levels up and can produce an estrone-to-estradiol ratio that does not reflect what the rest of your tissues are actually seeing.
Transdermal estrogen (patches, gels) bypasses the liver entirely, entering the bloodstream directly through the skin. This tends to produce more stable estradiol levels without the surge of estrone production and without driving the liver to ramp up production of clotting factors, inflammatory markers, and binding proteins the way oral estrogen does.17PubMed. Are all estrogens created equal? A review of oral vs. transdermal therapy
This difference is not trivial. The distinction between oral and transdermal estrogen can affect the ratio of estrone to estradiol by an order of magnitude, and a high ratio skewed toward estrone may mean the therapy is producing a lot of a weaker estrogen rather than delivering the potent estradiol that was intended. Your doctor may use the estrone-to-estradiol ratio from your blood test to decide whether your current route of delivery is working well or whether switching makes sense.
Estrone in Gender-Affirming Hormone Therapy
For transgender women and nonbinary individuals taking estradiol as part of feminizing hormone therapy, estrone levels have become a topic of increasing clinical interest. The route of estradiol delivery produces strikingly different estrone profiles. A study directly comparing routes in transfeminine individuals found that oral estradiol produced the highest estrone-to-estradiol ratio at 9.28, followed by sublingual at 6.88, while transdermal and injectable routes produced much lower ratios of 2.22 and 0.84 respectively.18PubMed Central. Comparison of Estrone/Estradiol Ratio and Levels in Transfeminine Individuals on Different Routes of Estradiol Oral and sublingual routes also showed far more variability from person to person.
There is a common concern in the trans health community that high estrone might interfere with feminization. A study following transfeminine individuals over 12 months of hormone therapy found that estrone concentrations were dramatically different between routes: roughly 187 pmol/L in transdermal users versus about 1,516 pmol/L in oral users. However, estrone concentrations were not associated with differences in fat redistribution or breast development in either group.19PubMed Central. The Role of Estrone in Feminizing Hormone Treatment That finding pushes back against the popular theory that estrone “blocks” feminization, though the study was limited in size and duration.
Sublingual estradiol, which is popular because it is convenient and avoids first-pass liver metabolism better than oral swallowing, still produces higher estrone levels than transdermal or injectable preparations. Researchers found that sublingual users with estradiol levels above 200 pg/mL tended to have particularly high estrone, while this pattern did not hold for transdermal or injectable users.20PubMed. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults If your clinician is ordering estrone alongside estradiol, they are likely evaluating whether your estrogen is being effectively delivered or whether a large share is being converted to the weaker form.
Alcohol, Diet, and Estrone
Lifestyle factors can nudge estrone levels in measurable ways. Alcohol is one of the better-studied influences. In a controlled feeding study of postmenopausal women, consuming roughly two standard drinks per day raised estrone sulfate by about 22% compared with placebo over four weeks. One drink per day produced a smaller, non-significant increase.21PubMed Central. The effects of moderate alcohol supplementation on estrone sulfate and DHEAS in postmenopausal women in a controlled feeding study In premenopausal women, the picture is more complicated. One study found that an acute dose of alcohol shifted the ratio of estradiol to estrone but did not significantly raise estrone itself.22Alcoholism: Clinical and Experimental Research. Acute Effect of Alcohol on Estradiol, Estrone, Progesterone, Prolactin, Cortisol, and Luteinizing Hormone in Premenopausal Women
This alcohol-estrone connection is one reason researchers have been interested in the link between moderate drinking and breast cancer risk in postmenopausal women. The mechanism appears to run partly through estrone sulfate: alcohol boosts the circulating reservoir, which tissues can then tap to produce active estrogen locally.
Body weight, as discussed earlier, has a larger and more consistent effect on estrone than alcohol does. But for someone whose estrone is borderline elevated, regular moderate-to-heavy drinking could be a contributing factor worth discussing with a doctor.
Estrone Sulfate as a Separate Test
Some labs report estrone sulfate rather than (or in addition to) free estrone. Estrone sulfate circulates at concentrations many times higher than free estrone and serves as a biologically inactive storage form. The body can convert estrone sulfate back into active estrone or estradiol in specific tissues through enzymes called sulfatases. This local activation is how tissues like the breast, uterus, and brain can regulate their own estrogen exposure independently of what the ovaries or adrenal glands are producing systemically.
Ovarian tumors in postmenopausal women can take advantage of this mechanism. Research has shown that ovarian tumor tissue can convert circulating estrone sulfate into estradiol, which may explain why some postmenopausal women with ovarian tumors have unexpectedly high estradiol levels despite no longer having functioning ovarian follicles.23PubMed. Conversion of circulating estrone sulfate to 17beta-estradiol by ovarian tumor tissue In clinical practice, estrone sulfate levels are sometimes tracked alongside aromatase inhibitor therapy to confirm that estrogen suppression is working adequately, and mass spectrometry-based assays are preferred for this purpose because of their superior accuracy at low concentrations.
When Estrone Was First Identified
Estrone holds a notable place in the history of hormone research: it was the first estrogen ever purified. In 1929, the American biochemist Edward Doisy crystallized estrone and announced the finding at an international physiology conference in Boston. The German chemist Adolf Butenandt had independently purified the same compound around the same time.24Endocrinology. History of Estrogen: Its Purification, Structure, Synthesis, Biologic Actions, and Clinical Implications Butenandt later received the Nobel Prize in Chemistry in 1939, in part for this work. The ability to measure estrone in blood came decades later, with radioligand assays appearing in the late 1960s and early 1970s, and mass spectrometry-based methods arriving in the 2000s. Each generation of measurement technology has shifted what clinicians consider “normal,” which is worth keeping in mind when comparing results across different eras of medical literature.